Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

Source :: GlobeNewswire. November 6, 2023
Publication Year :: 2023
Abstract: WALTHAM, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of https://www.globenewswire.com/Tracker?data=a9ucQcseIQXSWPGCwThmKQvxnmSYQcbMtYlpWE9bczu72z_PpOFltHY7bZGvWXcRLYbTpYQoDPwjvOwuxLCTNK-2tYpG-SbF4imFmYPDEak= (Sobi(R)), today announced that Health Canada has approved DOPTELET(R) (avatrombopag), an oral thrombopoietin [...]

Subjects :: Biological products
Liver
College teachers
Thrombocytopenia -- Care and treatment
Banking, finance and accounting industries
Business

Tools